Jaffar Khan
Director of Interventional Electrosurgery
St Francis Hospital and Heart Center
Director of Cardiovascular Innovation
St Francis Hospital and Heart Center
Associate Director of Structural Heart Research
St Francis Hospital and Heart Center
Jaffar Khan, MD is an Interventional Cardiologist at St Francis Hospital and Heart Center, Roslyn, where he is the Director of Interventional Electrosurgery, Director of Cardiovascular Innovation, and Associate Director of Structural Heart Research. He maintains an affiliation with the Laboratory of Cardiac Intervention at NHLBI, NIH, where he was previously a Staff Clinician. He has a special interest in structural heart disease innovation. Dr. Khan led the invention of transcatheter electrosurgical techniques to cut heart tissue, and together with a team of dedicated physicians and creative thinkers, invented several novel transcatheter procedures (LAMPOON, BASILICA, ELASTIC, SESAME, PASTA, Antepasta, TASTI and Khanno) that have been translated into clinical practice to help patients with mitral, aortic and tricuspid valve disease. He also contributed to the development of two devices that have completed early feasibility studies in the US (Mitral Cerclage Ventriculoplasty and Transcaval Closure Device).
Dr. Khan received his undergraduate degree at Cambridge as a Scholar, medical degree at Oxford with merits, and an award-winning doctorate in cardiovascular sciences at King's College London. He completed medical and general cardiology training in Oxford and London, and cardiology interventional fellowship at Washington Hospital Center. He received the NHLBI Director’s award, NHLBI Orloff award and NIH Director’s award, as well as the Young Investigator Awards at BCIS (UK) and AICS-PICS (USA). Dr. Khan is lead or associate investigator on 10 clinical 3 pre-clinical protocols. He has written over 130 peer-reviewed manuscripts and performed over 100 peer reviews. He is faculty at multiple international meetings and has given over 50 invited lectures, including 4 late breaking clinical trial presentations, as well as being a regular live case operator since 2016. His goal is to continue to contribute to device and procedure innovation and help bring these therapies to clinical practice to help patients.